Numerous Journals Featuring CytexOrtho Technology
News
Newsletter – January 2024
The January 2024 issue of the CytexOrtho newsletter covers our 2023 accomplishments, including receiving Breakthrough Device Designation from the FDA, and highlights what is on the horizon in 2024: the plan for hosting our first clinical trial and the launch of our...
Newsletter – June 2023
The June issue of the CytexOrtho newsletter covers our successful crowdfunding raise, our progress toward clinical trials, and our talk on capitol hill! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...
CytexOrtho on Capital Hill
On May 11th, 2023 Dr Brad Estes, CytexOrtho Co-founder and CEO, traveled to Washington D.C. to sit on a panel about the state of osteoarthritis (OA) in the United States, and the need for additional funding to move scientific advances combating OA to the clinic. The...
Breakthrough Device Designation from the FDA
We are thrilled to announce that we just received a Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for our novel hip cartilage repair technology. The intent of the Breakthrough Devices Program1 is to help patients have...
October Newsletter
The October issue of the CytexOrtho newsletter covers our progression toward clinical trials, discussions with the FDA, and our new CRP award from NIH! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...
In WRAL Techwire
CytexOrtho is in the news! WRAL Techwire featured a Startup Spotlight article about CytexOrtho on Monday, August 8th, 2022. According to WRAL: “Startup Spotlight is a regular feature in WRAL Techwire, bringing attention to promising emerging companies across the...
New Publication
We are pleased to announce that our research is featured on the cover of the August 2022 issue of the Journal of Orthopaedic Research! This review provides a summary of the research and development behind our osteochondral repair implant. The summary was the basis...
June Newsletter
The June issue of the CytexOrtho newsletter covers our progression toward clinical trials, discussions with the FDA, and our expanded presence on social media. If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via...
In Medical Textiles
Today we are pleased to announce that our novel cartilage regeneration implant is the lead story in the November issue of Medical Textiles. This feature references the publication in Science Advances, where CytexOrtho scientists demonstrate cartilage restoration in...
Kappa Delta Award
Today we are pleased to announce that the cofounders of CytexOrtho (formerly Cytex Therapeutics), Dr Farshid Guilak, Dr Bradley Estes, and Dr Frank Moutos have been granted the 2021 Kappa Delta Elizabeth Winston Lanier Award by the American Academy of Orthopedic...